RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-1.17%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.99B
AUM Growth
+$2.99B
(-15%)
Cap. Flow
-$78.8M
Cap. Flow
% of AUM
-2.64%
Top 10 Holdings %
Top 10 Hldgs %
48.59%
Holding
90
New
10
Increased
29
Reduced
22
Closed
15
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$114M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$86.8M |
| 3 |
ALLK
Allakos
ALLK
|
$61.1M |
| 4 |
IGMS
IGM Biosciences
IGMS
|
$55.8M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$55.1M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$405M |
| 2 |
eHealth
EHTH
|
$76.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
$62.6M |
| 4 |
Elevance Health
ELV
|
$51.8M |
| 5 |
Teladoc Health
TDOC
|
$30.7M |
Sector Composition
| 1 | Healthcare | 97.74% |
| 2 | Energy | 0.01% |
| 3 | Technology | 0% |
| 4 | Financials | 0% |
